| AEPFX | ATGDX | AEPFX / ATGDX | |
| Total Expense Ratio | 0.58 | 0.87 | 67% |
| Annual Report Gross Expense Ratio | 0.58 | 0.87 | 67% |
| Fund Existence | 17 years | 12 years | - |
| Gain YTD | 22.965 | 15.094 | 152% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 139B | 2.64B | 5,273% |
| Annual Yield % from dividends | 0.80 | 0.70 | 115% |
| Returns for 1 year | 16.41 | 13.75 | 119% |
| Returns for 3 years | 38.57 | 33.25 | 116% |
| Returns for 5 years | 11.50 | -2.90 | -397% |
| Returns for 10 years | 53.43 | 26.09 | 205% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHPCX | 14.55 | N/A | N/A |
| Saratoga Health & Biotechnology C | |||
| PRERX | 27.23 | -0.31 | -1.13% |
| Principal Real Estate Securities R3 | |||
| OASVX | 12.94 | -0.17 | -1.30% |
| Optimum Small-Mid Cap Value A | |||
| JSPIX | 29.82 | -0.58 | -1.91% |
| Jackson Square Large-Cap Growth Instl | |||
| GTSDX | 9.40 | -0.40 | -4.08% |
| Invesco Small Cap Growth C | |||